Skip to main content

MARTINGALE ASSET MANAGEMENT L P

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 936944 BOSTON, MA

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$13,027,483
+$5,490,945 QoQ
Shares Held
16,861
+72.7% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 70.93885297431943.ToString("F0")% Shared 0.ToString("F0")% None 29.06114702568057.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARTINGALE ASSET MANAGEMENT L P holds $113,855,320 across 56 Biotechnology names. REGN ranks #3 (11.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
16,861 $13,027,483

All Filings in REGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,027,483 16,861
2025-12-31 $7,536,538 9,764
2025-06-30 $1,363,950 2,598
2025-03-31 $7,354,531 11,596
2024-12-31 $14,394,764 20,208
2024-09-30 $22,823,471 21,711
2024-06-30 $27,519,117 26,183
2024-03-31 $28,356,879 29,462
2023-12-31 $28,792,102 32,782
2023-09-30 $28,190,494 34,255
2023-06-30 $26,120,366 36,352
2023-03-31 $31,512,687 38,352
2022-12-31 $28,050,809 38,879
2022-09-30 $29,281,107 42,506
2022-06-30 $26,207,748 44,335
2022-03-31 $33,440,349 47,880
2021-12-31 $32,398,239 51,302
2021-09-30 $32,895,164 54,356
2021-06-30 $36,399,493 65,169
2021-03-31 $32,344,323 68,361
2020-12-31 $30,852,853 63,863
2020-09-30 $29,743,350 53,134
2020-06-30 $25,063,246 40,188